The Latest Cardiac and Vascular News
– Acceleron expects to report approximately $22.4 million in royalty revenue for Q1 2021 from approximately $112 million in net sales of REBLOZYL® (luspatercept-aamt) as reported by Bristol Myers Squibb – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Acceleron Pharma Inc. (Nasdaq:XLRN), a biopharmaceutical company dedicated to the discovery, development, and commercialization of TGF-beta superfamily therapeutics […]
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced first quarter 2021 financial results. “Our growth in the first quarter is a testament of our team’s strong execution and unwavering dedication despite continued COVID headwinds,” said […]
LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended March 31, 2021. For the first quarter of 2021, worldwide sales from continuing operations were $247.6 million, an increase of 2.1 percent on a reported basis and a decline of 0.4 […]
OXFORD, England, April 28, 2021 /PRNewswire/ — GEN inCode UK Limited, the cardiovascular disease company focused on predictive genetics for the prevention of cardiovascular disease, announces today a collaboration with Royal Brompton and Harefield hospitals (“RB&H”), recently merged with Guy’s and St Thomas’ NHS Foundation Trust (“GSTT”), to provide globally leading cardiovascular disease clinical genetic […]
MARLBOROUGH, Mass., April 28, 2021 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.752 billion during the first quarter of 2021. This represents growth of 8.2 percent on a reported basis, 5.6 percent on an operational1 basis and 5.9 percent on an organic2 basis, all compared to the prior year period. The company reported GAAP […]
STOCKHOLM, April 28, 2021 /PRNewswire/ — Strongest order intake in Mentice’s history despite the corona pandemic First quarter (January-March 2021) Order intake amounted to 39.9 (32.5) MSEK. Order book by end of the period was 72.9 (33.9) MSEK. Net sales amounted to 32.3 (33.8) MSEK. Operating income for the period before depreciations (EBITDA) […]
€1.5 million guaranteed by the French government (PGE) and granted by BNP bank €1.5 million innovation and R&D loan granted by Bpifrance Funding will allow for acceleration of R&D programs PARIS, April 28, 2021 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the […]
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (NASDAQ:ABMD) announces the appointment of Paula A. Johnson, MD, MPH, to the Abiomed Board of Directors, effective immediately. Dr. Johnson will serve as a member of the Governance and Nominating Committee of the board. Following the appointment of Dr. Johnson, the board now comprises nine active directors. “Dr. […]
The new name reflects the company’s commitment to pediatric, critical care, and chronic heart failure patients EDEN PRAIRIE, Minn., April 27, 2021 (GLOBE NEWSWIRE) — Company names are reflective of the services provided to its customers, and CHF Solutions – a leader and pioneer in the heart failure space – […]
-Xenter’s next-generation technology advances interventional medicine by integrating functions that formerly required multiple devices- SALT LAKE CITY–(BUSINESS WIRE)–On the heels of its April 7 launch announcement, Xenter, Inc. (XenterMD.com), the world’s first start-up Device-Data-Drug healthcare technologies company, today announced that James R. Tobin has been appointed to the company’s Board of Directors. Founded […]
